Dr. Jose Luis Valladares, MD

Dr. Valladares practices at The Oncology Institute of Hope and Innovation in Cerritos, California.

Dr. Valladares' NPI, 1053303255, was assigned on August 16, 2005. Dr. Valladares graduated from National University of San Marcos in 1980. Dr. Valladares' Texas license number on file is L5595.

Dr. Valladares' primary practice is The Oncology Institute of Hope and Innovation, at 18000 Studebaker Rd, Cerritos, CA 90703 in Los Angeles County. The practice phone is (702) 342-1244.

Dr. Valladares' primary practice is The Oncology Institute of Hope and Innovation in Cerritos, California. The medical group on file is The Oncology Institute of Hope and Innovation. Dmand AI also links Dr. Valladares to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valladares practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Valladares' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Valladares is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Valladares' licenses on file in 4 states: Texas, Nevada, Illinois and Michigan.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Valladares treats.

CMS data shows 489 Medicare services from Dr. Valladares across 10 procedure codes in 2024, for 150 Medicare patients. Medicare paid $44,070 for them. Every service was in an office.

CMS counts 150 Medicare patients who saw Dr. Valladares in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Valladares' median patient age at 70, with 61% women.

In 2024, Dr. Valladares wrote 510 Medicare Part D claims for 192 patients. 71% of them were for generic drugs. CMS names the drug for 263 of them, across 11 drugs with 11 or more claims each, at $278,896 in total drug cost. In 2023, CMS named 763 claims across 23 drugs.

Dr. Valladares accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 949 general payments to Dr. Valladares from 75 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Pfizer Inc. paid the most, $1,630.

Dr. Valladares graduated from National University of San Marcos in 1980.

Dr. Valladares is in network with 23 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.